TELA

TELA Bio, Inc. TELA

TELA
TELA Bio, Inc. TBIO
Telesis Bio, Inc. RCEL
AVITA Medical, Inc. CLPT
ClearPoint Neuro, Inc. SGHT
Sight Sciences, Inc. TMCI
Treace Medical Concepts, Inc. XGN
Exagen Inc. PHAT
Phathom Pharmaceuticals, Inc. KROS
Keros Therapeutics, Inc. TARA
Protara Therapeutics, Inc.

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode TELA TBIO RCEL CLPT SGHT TMCI XGN PHAT KROS TARA
6M 49.13 % -98.80 % -40.37 % 127.64 % 34.45 % -12.76 % 157.04 % 142.21 % 28.90 % 33.50 %
YTD -49.31 % -97.00 % -59.81 % 68.02 % -10.61 % -25.29 % 254.37 % 61.26 % -1.38 % -6.45 %
1Y -41.37 % -99.57 % -50.62 % 110.39 % -48.22 % 13.08 % 305.56 % -22.64 % -74.05 % 186.81 %
3Y -82.26 % -99.96 % 10.78 % 156.74 % -47.88 % -74.43 % 319.54 % 18.56 % -65.78 % 43.01 %
5Y -91.09 % -100.00 % -80.40 % 366.25 % -90.45 % -76.97 % -25.56 % -70.11 % -66.57 % -72.31 %
10Y -89.06 % -100.00 % -41.92 % 14.52 % -90.45 % -76.97 % -41.07 % -51.95 % -21.81 % -99.11 %
From the beginning -89.06 % -100.00 % -79.44 % -12.97 % -90.45 % -76.97 % -41.07 % -51.95 % -21.81 % -98.70 %

Dividend